Title |
Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil
|
---|---|
Published in |
BMC Infectious Diseases, September 2011
|
DOI | 10.1186/1471-2334-11-247 |
Pubmed ID | |
Authors |
Maria Cassia Mendes-Correa, João RR Pinho, Michele S Gomes-Gouvea, Adriana C da Silva, Cristina F Guastini, Luiz G Martins, Andréa G Leite, Mariliza H Silva, Reinaldo J Gianini, David E Uip |
Abstract |
HBV-HIV co-infection is associated with an increased liver-related morbidity and mortality. However, little is known about the natural history of chronic hepatitis B in HIV-infected individuals under highly active antiretroviral therapy (HAART) receiving at least one of the two drugs that also affect HBV (TDF and LAM). Information about HBeAg status and HBV viremia in HIV/HBV co-infected patients is scarce. The objective of this study was to search for clinical and virological variables associated with HBeAg status and HBV viremia in patients of an HIV/HBV co-infected cohort. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 25% |
Unknown | 3 | 75% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 2 | 3% |
United States | 1 | 2% |
Unknown | 56 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 18 | 31% |
Student > Master | 10 | 17% |
Student > Postgraduate | 5 | 8% |
Student > Doctoral Student | 4 | 7% |
Other | 4 | 7% |
Other | 8 | 14% |
Unknown | 10 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 42% |
Nursing and Health Professions | 5 | 8% |
Agricultural and Biological Sciences | 4 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Immunology and Microbiology | 3 | 5% |
Other | 6 | 10% |
Unknown | 13 | 22% |